// App-Quantinova.ai

ABS206 : UPTAKE OF EMICIZUMAB FOR PROPHYLAXIS IN CHILDREN WITH SEVERE HAEMOPHILIA A < 12 YEARS OF AGE IN THE UK.

Researchers

Presenter

  • M. Mathias

Principal Investigators

  • J. Alamelu

  • N. Bhatnagar

  • T. Biss

  • J. Grainger

  • S. Green

  • A. Kelly

  • J. Motwani

  • S. Stokley

  • E. Chalmers

  • J. Payne

Medical Centers

  • Great Ormond Street Hospital

  • Evelina London Childrens Hospital, London, UK

  • Oxford University Trust, Oxford

  • Newcastle Upon Tyne Hospitals NHS Trust, Newcastle

  • Royal Manchester Children's Hospital, Manchester, GBR

  • Hull University Hospitals NHS Trust, Hull

  • Addenbrookes University Trust, Cambridge

  • Birmingham City Hospital, Birmingham

  • Nottingham University hospital, U.K., Nottingham,

  • Royal Hospital for Children, Glasgow, Glasgow

  • Sheffield Children’s NHS Trust

  • Sheffield Children’s NHS Foundation Trust

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved